KRAS and non-small cell lung carcinoma: However, the KRAS gene is frequently mutated in a variety of human cancers, especially non–small cell lung cancer (NSCLC), colorectal cancer, and pancreatic ductal adenocarcinoma (PDAC), resulting in the oncogenic activation of the KRAS protein (2, 3).